Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases ...

Eli Lilly & Co. is tapping the US investment-grade bond market on Monday to help finance its roughly $2.5 billion purchase of ...

Drugmaker Incyte Corp reported fourth-quarter revenue above Wall Street estimates on Monday, boosted by strong demand for its key blood-cancer drug Jakafi and skin-disorder treatment Opzelura.

Cannabidiol may reduce scan-related anxiety among women with advanced breast cancer, according to results of randomized phase ...

Chemotherapy for breast cancer may be more effective during specific stages of the menstrual cycle, according to data from ...

A Mercyhurst professor said many worry about how artificial intelligence might disrupt their lives. Students, meanwhile, are ...

The Food and Drug Administration has revoked use of the synthetic dye Red No. 3 — approved to provide color in food and drugs ...

The clinical trial, known as the CDK4/6 Inhibitor Dosing Knowledge Study, is investigating personalized dosing strategies for ...

Everyday painkillers, antibiotics, cancer medications, blood thinners and more are just some of the drugs that the U.S.

Grants from the National Institutes of Health come with additional money for overhead. A planned $4 billion cut would leave ...

The American Cancer Society is calling on the Trump administration to restore access to comprehensive scientific data.

The shortage of generic chemotherapy drugs cisplatin and carboplatin that began in early 2023 did not increase short-term ...